NAIROBI, Kenya – The Pharmacy and Poisons Board’s Enquiries and Disciplinary Committee (EDC) has suspended the licences of four pharmaceutical practitioners for alleged professional misconduct.
Chairperson Richard Muthoka announced that two pharmaceutical technologists received two-year suspensions for what the board deemed serious violations.
These practitioners were accused of allowing unlicensed individuals to access their professional credentials, as well as permitting unauthorized personnel to manage their licensed premises—actions that jeopardized public safety.
“This level of negligence exposes the public to unacceptable risks. Those entrusted with the responsibility of managing pharmaceutical practices must adhere to the highest standards,” said Muthoka in a statement.
A third practitioner received a three-month suspension for failing to ensure the proper closure of their former premises, which allowed an unqualified person to continue operations, further endangering public safety.
In a separate ruling, the Committee imposed a three-year suspension on a pharmaceutical technologist for allegedly impersonating a student during the Board’s May 2024 examination series.
“After a thorough review of the facts and your written confessions, the Board concludes that your actions represent a serious breach of trust and integrity—qualities essential for anyone in the pharmaceutical field,” read the committee’s decision.
The Board reaffirmed its commitment to regulating the pharmacy profession rigorously, underscoring that maintaining integrity within the sector is crucial to protecting the public.
Chairperson Richard Muthoka announced that two pharmaceutical technologists received two-year suspensions for what the board deemed serious violations.
These practitioners were accused of allowing unlicensed individuals to access their professional credentials, as well as permitting unauthorized personnel to manage their licensed premises—actions that jeopardized public safety.
“This level of negligence exposes the public to unacceptable risks. Those entrusted with the responsibility of managing pharmaceutical practices must adhere to the highest standards,” said Muthoka in a statement.
A third practitioner received a three-month suspension for failing to ensure the proper closure of their former premises, which allowed an unqualified person to continue operations, further endangering public safety.
In a separate ruling, the Committee imposed a three-year suspension on a pharmaceutical technologist for allegedly impersonating a student during the Board’s May 2024 examination series.
“After a thorough review of the facts and your written confessions, the Board concludes that your actions represent a serious breach of trust and integrity—qualities essential for anyone in the pharmaceutical field,” read the committee’s decision.
The Board reaffirmed its commitment to regulating the pharmacy profession rigorously, underscoring that maintaining integrity within the sector is crucial to protecting the public.
